EUVIMEDEUVIMED entdecken
Crossref

Machine learning algorithms integrating positron emission tomography/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer

Zhenxin Sheng, Shuyu Ji, Yancheng Chen, Zirong Mi, Huansha Yu, Lele Zhang, Shiyue Wan, Nan Song, Ziyun Shen, Peng Zhang iD

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Zhenxin Sheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lung Neoplasms, Neoadjuvant Therapy, Machine Learning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Innovation Program of Shanghai Municipal Education Commission, Shanghai Science and Technology Committee, Foundation of Shanghai Pulmonary Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Reliable methods for predicting pathological complete response (pCR) in non-small cell lung cancer (NSCLC) patients undergoing neoadjuvant chemoimmunotherapy are still under exploration. Although Fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG PET/CT) features reflect tumour response, their utility in predicting pCR remains controversial. METHODS This retrospective analysis included NSCLC patients who received neoadjuvant chemoimmunotherapy followed by 18F-FDG PET/CT imaging at Shanghai Pulmonary Hospital from October 2019 to August 2024. Eligible patients were randomly divided into training and validation cohort at a 7:3 ratio. Relevant 18F-FDG PET/CT features were evaluated as individual predictors and incorporated into 5 machine learning (ML) models. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), and Shapley additive explanation was applied for model interpretation. RESULTS A total of 205 patients were included, with 91 (44.4%) achieving pCR. Post-treatment tumour maximum standardized uptake value (SUVmax) demonstrated the highest predictive performance among individual predictors, achieving an AUC of 0.72 (95% CI 0.65–0.79), while ΔT SUVmax achieved an AUC of 0.65 (95% CI 0.53–0.77). The Light Gradient Boosting Machine algorithm outperformed other models and individual predictors, achieving an average AUC of 0.87 (95% CI 0.78–0.97) in training cohort and 0.83 (95% CI 0.72–0.94) in validation cohort. Shapley additive explanation analysis identified post-treatment tumour SUVmax and post-treatment nodal volume as key contributors. CONCLUSIONS This ML models offer a non-invasive and effective approach for predicting pCR after neoadjuvant chemoimmunotherapy in NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLung NeoplasmsNeoadjuvant TherapyMachine LearningCarcinoma, Non-Small-Cell LungImmunotherapyHumansMaleFemaleRetrospective StudiesMiddle AgedAgedFluorodeoxyglucose F18Treatment OutcomeRadiopharmaceuticals

Stichwörter der Autor:innen

18F-FDG PET/CTMachine learningNeoadjuvant therapyNon-small cell lung cancerSUVmax

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Information Service Department, Orient Overseas Container Line Limited, Shanghai, China.
  • Department of Thoracic Surgery, Medical College of Shihezi University, Shihezi, China.
  • Experimental Animal Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Peng Zhang

Förderung

  • Innovation Program of Shanghai Municipal Education Commission
  • Shanghai Science and Technology Committee
  • Foundation of Shanghai Pulmonary Hospital
  • National Natural Science Foundation of China

Zitieren

APA

Sheng, Z., Ji, S., Chen, Y., Mi, Z., Yu, H., Zhang, L., Wan, S., Song, N., Shen, Z., & Zhang, P. (2025). Machine learning algorithms integrating positron emission tomography/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf132

Vancouver

Sheng Z, Ji S, Chen Y, Mi Z, Yu H, Zhang L, et al. Machine learning algorithms integrating positron emission tomography/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf132

BibTeX
@article{Sheng2025,
  author = {Sheng, Zhenxin and Ji, Shuyu and Chen, Yancheng and Mi, Zirong and Yu, Huansha and Zhang, Lele and Wan, Shiyue and Song, Nan and Shen, Ziyun and Zhang, Peng},
  title = {Machine learning algorithms integrating positron emission tomography/computed tomography features to predict pathological complete response after neoadjuvant chemoimmunotherapy in lung cancer},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf132}
}
Kostenlos starten →